Over the next ten years, PBMs and specialty pharmacies will save payers and patients an estimated total of $250 billion on the cost of specialty medications and related non-drug medical costs when compared to what expenditures would be with limited use of PBMs and specialty pharmacies.
Learn MoreDrug Coupons & Assistance Programs
Fraud, Waste & Abuse
Value & Outcome-Based Contracting
Drug Coverage Mandates
Pharmacy Contracting & Reimbursement
Drug Abuse Prevention
PCMA hosts three annual events: the sPCMA Business Forum, the PBM Policy Forum, and the PCMA Annual Meeting
PCMA’s conference brand is known for bringing together thought leaders and pharmacy benefit decision makers from PBMs, specialty pharmacies, and pharma and biotech manufacturers.
Learn MorePCMA Offers to Work with FDA chief Scott Gottlieb to Address the Opioid Crisis
July 25, 2017
The Pharmaceutical Care Management Association (PCMA) has outlined solutions that would help assure people receive opioid prescriptions only when medically...
PCMA Issues Guiding Principles, Policy Solutions to HHS on Reducing Prescription Drug Costs
July 18, 2017
(Washington, D.C.) -- The Pharmaceutical Care Management Association (PCMA) recently submitted a letter to HHS Secretary Tom Price offering policy...
July 12, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) has filed a lawsuit in federal court challenging two North Dakota...
PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.